Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
123.76
+1.18 (0.97%)
Sep 16, 2025, 1:44 PM EDT
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $238.00 billion as of September 16, 2025. Its market cap has decreased by -2.51% in one year.
Market Cap
238.00B
Enterprise Value
264.00B
Revenue
55.19B
Ranking
n/a
PE Ratio
17.43
Stock Price
$123.76
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 238.00B, an increase of 86.89%. That is a compound annual growth rate of 2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 238.00B | 21.73% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | 215.32B | 0.17% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |